UA87524C2 - Benzothiazole formulations with a macrogol glyceride and use thereof - Google Patents

Benzothiazole formulations with a macrogol glyceride and use thereof

Info

Publication number
UA87524C2
UA87524C2 UAA200704715A UAA200704715A UA87524C2 UA 87524 C2 UA87524 C2 UA 87524C2 UA A200704715 A UAA200704715 A UA A200704715A UA A200704715 A UAA200704715 A UA A200704715A UA 87524 C2 UA87524 C2 UA 87524C2
Authority
UA
Ukraine
Prior art keywords
benzothiazole
macrogol glyceride
formulations
glyceride
benzothiazole formulations
Prior art date
Application number
UAA200704715A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
П'єрандреа Еспозіто
Деніела Кікко
Лука Донаті
Андреа Леонарді
Стефанія Бертеро
Жан-П'єр Готтлан
Паскаль Гейяр
Ізабель Жанклод-Етте
Сімоне Грандоліні
Маріо Майо
Original Assignee
Ейрес Трейдінг С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ейрес Трейдінг С.А. filed Critical Ейрес Трейдінг С.А.
Publication of UA87524C2 publication Critical patent/UA87524C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The present invention is related to macrogog glyceride pharmaceutical formulations containing benzothiazole derivatives. In particular, the invention is related to benzothiazole stearoyl macrogol pharmaceutical formulations, method of preparation and use thereof.
UAA200704715A 2004-11-17 2005-11-16 Benzothiazole formulations with a macrogol glyceride and use thereof UA87524C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04105843 2004-11-17

Publications (1)

Publication Number Publication Date
UA87524C2 true UA87524C2 (en) 2009-07-27

Family

ID=34929876

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200704715A UA87524C2 (en) 2004-11-17 2005-11-16 Benzothiazole formulations with a macrogol glyceride and use thereof

Country Status (4)

Country Link
CN (1) CN101102796A (en)
RS (1) RS51119B (en)
UA (1) UA87524C2 (en)
ZA (1) ZA200703998B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014114186A1 (en) * 2013-01-24 2014-07-31 山东亨利医药科技有限责任公司 Jnk inhibitors
HUE072464T2 (en) * 2019-01-31 2025-11-28 Spinogenix Inc Solid forms of a promoter of spinogenesis
CN116836084A (en) * 2023-07-19 2023-10-03 上海绿智创领医药科技有限公司 Preparation method and application of p-cyanobenzoic acid

Also Published As

Publication number Publication date
ZA200703998B (en) 2008-11-26
CN101102796A (en) 2008-01-09
RS51119B (en) 2010-10-31

Similar Documents

Publication Publication Date Title
IL220480A0 (en) 1-benzyl-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors , preparation method thereof, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
IL184735A0 (en) Pharmaceutical formulations and methods of use
TW200618817A (en) Diffractive colorants for cosmetics
IL192053A (en) 2-adamantylurea derivatives as selective 11beta-hsd1 inhibitors and the use thereof in the preparation of medicaments
ZA200705750B (en) Compositions and methods for stabilizing active pharmaceutical ingredients
EP1724278A4 (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
SI2013166T1 (en) N-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical use
MX2009006327A (en) Heterocycle compounds and methods of use thereof.
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
IL195493A0 (en) Combination preparations comprising bifeprunox and l-dopa
WO2006053882A3 (en) Benzothiazole formulations and use thereof
LT1807156T (en) New pharmaceutical formulations useful in the treatment of insomnia
IL191992A0 (en) Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
PL1828137T3 (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
UA87524C2 (en) Benzothiazole formulations with a macrogol glyceride and use thereof
MX2007010930A (en) Formulation for aviptadil.
MY146444A (en) Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases
EP1885381A4 (en) Pharmaceutical use of graptopetalum and related plants
CA116927S (en) Container
TW200716581A (en) Benzothiazol-2-one derivatives as inhibitors of lipases and phospholipases
AU302434S (en) Vibroheat capsule I
GB0518579D0 (en) Controlled delivery creatine formulations and method of using the same
ZA200704650B (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
GB0408955D0 (en) Pteridine derivatives useful as pharmaceutical ingredients
IL196824A0 (en) Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy